– USA, NJ – WCG, the global leader in providing solutions that improve and accelerate clinical research, today announced the appointments of Ken Getz, Bob Hugin, and Dr. Amrit Ray (MD) to its board of directors, bringing a wealth of experience and expertise to guide the continued growth and value creation at WCG.
About Ken Getz
Ken Getz is the executive director of the Tufts Center for the Study of Drug Development and a renowned industry thought leader. He is an expert in drug research and development, clinical trial management practices, patient engagement, and industry trends. Getz also serves as a research professor at Tufts University School of Medicine, Public Health, and Community Medicine and is the founder of the clinical research non-profit, CISCRP.
About Bob Hugin
Bob Hugin is the former CEO and chairman of Celgene and former chairman of the board of The Pharmaceuticals Research and Manufacturers of America. With a notable background as a director of various corporations, including Chubb Limited and Biohaven Pharmaceuticals Inc., Hugin brings invaluable insights into corporate leadership, strategy, and governance.
About Dr. Amrit Ray
Amrit Ray is the former global president and head of R&D at Pfizer Upjohn. As a distinguished physician-researcher, Dr. Ray enhances the board with his extensive biopharmaceuticals experience across research, phases I – IV development, regulatory, safety, and medical affairs on a global scale. Along with his board director experience at companies such as Fortrea, Ultragenyx, and Press Ganey, Dr. Ray is a trustee at The Hastings Center for Bioethics and serves on the steering group of the Good Clinical Trials Collaborative, reflecting his commitment to patient advocacy and advancing global healthcare.
About WCG
WCG is a global leader in solutions that measurably improve and accelerate clinical research. Biopharmaceutical and medical device companies, contract research organizations, research institutions, and sites partner with us for our unmatched expertise, data intelligence, and purpose-built technology to make informed decisions and optimize study outcomes, while maintaining the highest standards of human participant protection. WCG raises the bar by pioneering new concepts, reimagining processes, fostering compliance and safety, and empowering those who perform clinical trials to accelerate the delivery of medical therapies and devices that improve lives.
For more information: https://www.wcgclinical.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
